APN Resources H2 Earnings Call Highlights

Applied Nutrition reported a 50.9% rise in fiscal 2026 revenue and forecast further growth in fiscal 2027, as the sports nutrition company invests in U.K. production capacity and expands its manufacturing presence in the United States.

Revenue rose to £161.6 million, while adjusted earnings before interest, taxes, depreciation and amortization increased 40.1% to £43.3 million. The company said it expects fiscal 2027 revenue of approximately £205 million and adjusted EBITDA of approximately £49 million, in line with market expectations.

Growth came across every region, with each recording a revenue increase of at least 34%, Group CFO Joe Pollard said. Management said momentum had continued into the first quarter of fiscal 2027.

Sales Growth and Margin Pressures

U.K. revenue grew 45.2%, supported by growth of 65% in high street health stores and 180% in grocers. European revenue rose 34%, while international sales increased 63.3%. Pollard said Latin American sales grew 190% and Asia-Pacific sales rose almost 60%.

Gross profit climbed 44.6% to £71.3 million, although gross margin declined to 44.1% from 46%. Adjusted EBITDA margin was 26.8%.

Pollard attributed much of the gross margin movement to staff costs, including pay increases, overtime and inefficiencies associated with using multiple temporary warehouses. The company expects automation and the opening of its new global headquarters in the second half of fiscal 2027 to help reduce some of those costs.

For fiscal 2027, Pollard said a greater contribution from the U.S., where margins are lower, would affect the group’s gross margin. He also expects average whey protein costs to be higher than in fiscal 2026, despite a recent decline in prices. Recent price increases will mitigate some of that impact, he said, but the company cannot pass all raw material increases on to customers.

Pollard said the company’s priority is to grow EBITDA rather than focus exclusively on its margin. Large orders of lower-margin whey products, for example, could dilute the percentage margin while increasing EBITDA in absolute terms, he said.

U.K. Expansion and U.S. Acquisition

Group COO Steven Granite said the company had outgrown its warehousing facilities and was using four third-party logistics providers in addition to its own sites. New capacity is expected to eliminate off-site third-party storage and support approximately £300 million in revenue, excluding the U.S., he said.

The U.K. phase III production expansion is expected to be completed by the end of the calendar year. Granite said it would increase annual U.K. production capacity from £200 million to £300 million. The company is also building a new global headquarters and distribution facility.

In June, Applied Nutrition acquired the trade and assets of Nutrablend, a sports nutrition manufacturer in Buffalo, New York. Granite said the $16 million investment included the building, inventory, machinery, customer base and brand intellectual property. The facility has the capacity to produce up to $300 million in annual revenue, he said.

Applied Nutrition plans to use the site for white-label manufacturing while developing its own brands in the U.S. Granite said the U.S. business is expected to enhance earnings in fiscal 2027 after being loss-making in fiscal 2026, though its margins will be lower than those in the U.K.

Pollard reiterated the company’s prior expectation that the acquired business would contribute roughly $30 million in sales and single-digit EBITDA at that level. Management said it expects work to improve the U.S. production lines to take about nine months, with two or three lines operating during that period.

Cash and Capital Returns

Applied Nutrition ended fiscal 2026 with £15.9 million in net cash and £30 million of undrawn borrowing facilities. Pollard said working capital use increased 68%, outpacing revenue growth, partly because of higher stockholdings, increased whey prices and inventory acquired with Nutrablend.

The board does not expect to declare a dividend or initiate share buybacks before fiscal 2028. Pollard said the company would consider returning cash when the board believes its balance-sheet cash exceeds what may reasonably be needed for the business.

Asked about a free cash flow rebound, Pollard said the company would continue to recapitalize the U.S. business in the first half of fiscal 2027. The timing of an improvement in the second half would depend on growth rates and associated working capital needs, he said.

About APN Resources (LON:APN)

Applied Nutrition plc (LSE: APN) is a leading sports nutrition, health and wellness brand, which formulates and creates nutrition products with a stated aim of being the world’s most trusted and innovative brand in the market. Headquartered in the UK, the Group sells products in over 85 countries worldwide and has a diverse product range, targeting elite athletes, gym goers and health-conscious consumers. Applied Nutrition has developed and launched four ranges under the umbrella of the Applied Nutrition brand – Applied Nutrition, ABE, BodyFuel, and Endurance.